WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

http://www.aastocks.com/en/stocks/news/aafn-con/now.1244673/latest-news

https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/does-wuxi-biologics-cayman-hkg2269-deserve-a-spot-on-your-wa/amp

https://www.marketscreener.com/amp/quote/stock/WUXI-BIOLOGICS-CAYMAN-I-37230806/news/WuXi-Biologics-Receives-the-Asset-ESG-Corporate-Platinum-Award-for-Second-Consecutive-Year-42955659/

10 minutes with Shauna McCabe- WuXi Biologics https://www.breakingnews.ie/amp/advertising-feature/10-minutes-with-shauna-mccabe-wuxi-biologics-1430970.html

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1242734/popular-news/HK6

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1242682/company-news/HK6

WuXi Biologics erweitert Standort https://www.wuppertal.de/presse/meldungen/meldungen-2023/januar/wuxi.php

WuXi Bio ist die Tochter der AppTec und das Portfolio lässt sich am besten auf deren Seiten herauslesen. Wäre daher nicht gerecht, die AppTec eher dem chemisch-pharmazeutischen Bereich zuzuordnen und die Bio auf die End-to-end Lösungen zu reduzieren.

Was ist der Unterschied zwischen WuXi Biologic und Wuxi Apptac ?

https://e-fundresearch.com/newscenter/167-comgest/artikel/46581-comgest-fondsmanager-chen-gelingt-china-im-jahr-des-hasen-das-comeback

Bank of America Securities Upgrades WuXi Biologics (02269 HK) to "Buy" and Raises Target Price to $114.6 http://www.aastocks.com/tc/stocks/news/aafn-con/now.1239489/latest-news

https://www.wuppertal.de/presse/meldungen/meldungen-2023/januar/102010100000464653.php

...After the completion, WuXi Biologics Holdings' shareholding will be reduced from about 15.14% to 13.82%, and it will continue to be the company's major shareholder. Allotment shareholders promise a 3-month lock-up period. Li Ge, chairman and non-executive director of the group, has about 19.66% of the control over WuXi Biologics Holdings and 55.03% of the votes at the general meeting of shareholders. WuXi Biologics Holdings holds about 640 million shares of WuXi Biologics, accounting for about 15.14% of the total issued share capital of the company.

https://www.stheadline.com/finance-live/3189053/%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9%E5%A4%A7%E8%82%A1%E6%9D%B1%E6%8A%98%E8%AE%9339%E6%B8%9B%E6%8C%815600%E8%90%AC%E8%82%A1-%E5%A5%97398%E5%84%84%E5%85%83

Wuxi  Bio Dives 4% as Major Shareholder Ditches 1.3% Stake at Over 3.9% Discount http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1239413/company-news/HK6

Big Bank Rating | Goldman Sachs: Quoted from WuXi Biologics (2269 HK) that it will focus on increasing market share in the future and maintain a target price of HK$93 https://finance.sina.cn/hkstock/sckxjfx/2023-01-13/detail-imxzzrzh2340607.d.html?from=wap